Gilead Sciences Inc at Bank of America Healthcare Conference Transcript
Sessions of the Bank of America Healthcare Conference. So my name is Geoff Meacham. I'm the senior biopharma analyst here. And my colleague, Jason Zemansky, is with me on stage as well. And we're thrilled to have Andy Dickinson today, who is CFO of Gilead Sciences. Andy?
Thank you. Thanks. I'm thrilled to be here. Thank you for having us.
Questions & Answers
Yes. Just to kick it off, following the quarter, there's a lot of questions we get, Andy, about a lot of the puts and takes in the P&L from the R&D expenses that are now included, some of the changes to repatriation tax. I want to get maybe a high-level view of all the puts and takes from a P&L and a cash perspective for Gilead, and then we can get into sort of the strategy kind of questions on some of the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
